How to survive (and maybe even benefit from) Medicare Advantage and prescription drug bid reviews and audits

  • Print
  • Connect
  • Email
  • Facebook
  • Twitter
  • LinkedIn
  • Google+
By Michael C. Cook | 20 June 2011
While few would say that responding to Medicare Avantage bid reviews or audits is an enjoyable experience, it does not need to be entirely negative. This article discusses some of the strategies that plan sponsor actuaries and other Medicare team members can take before, during, and after reviews and audits to make them as painless as possible while improving the quality of bid development and business planning processes.